Crossmark

Rationality over convenience: The CDSCO’s regulatory ban on irrational antidiabetic fixed-dose combinations in India and its clinical-pharmacological imperatives

Crossref DOI link: https://doi.org/10.1007/s13410-025-01501-1

Published Online: 2025-05-17

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Samajdar, Shambo Samrat https://orcid.org/0000-0002-9199-0905
Joshi, Shashank R.

Husain, Noor https://orcid.org/0009-0002-6925-8926
Bisht, Khushboo

Venkatraman, Shravan

Mukherjee, Shatavisa

Chawla, Rajeev
License Information

Text and Data Mining valid from 2025-05-17

Version of Record valid from 2025-05-17
More Information

Article History

Received: 25 April 2025

Accepted: 28 April 2025

First Online: 17 May 2025

Declarations

:

: Not applicable. This study is a non-interventional policy and scientific review based solely on publicly available regulatory documents and published literature. No human participants, patient data, or institutional permissions were involved.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below